International Journal of Tuberculosis and Lung Disease

Papers
(The H4-Index of International Journal of Tuberculosis and Lung Disease is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
The impact of COVID-19 on TB: a review of the data178
The Global Asthma Report 202278
Clinical standards for the assessment, management and rehabilitation of post-TB lung disease78
Impact of COVID-19 on TB diagnosis in Northeastern Brazil44
Post-TB health and wellbeing36
Clinical standards for the diagnosis, treatment and prevention of TB infection35
The COVID-19 and TB syndemic: the way forward34
A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB30
Clinical standards for the dosing and management of TB drugs28
The burden and determinants of post-TB lung disease25
Diagnosing pulmonary aspergillosis is much easier than it used to be: a new diagnostic landscape23
Persistent chronic respiratory symptoms despite TB cure is poorly correlated with lung function23
Pulmonary TB and chronic pulmonary aspergillosis: clinical differences and similarities22
Household air pollution and COPD: cause and effect or confounding by other aspects of poverty?22
Comparative analysis of Truenat™ MTB Plus and Xpert® Ultra in diagnosing tuberculous meningitis20
Thrombotic events and COVID-19 vaccines20
The rise of artificial intelligence reading of chest X-rays for enhanced TB diagnosis and elimination20
Impact of shelter-in-place on TB case notifications and mortality during the COVID-19 pandemic19
Chronic obstructive pulmonary disease in sub-Saharan Africa18
Real-world implementation of video-observed therapy in an urban TB program in the United States18
WHO drug-resistant TB guidelines 2022: what is new?18
TB and COVID-19 co-infection: rationale and aims of a global study18
A randomised controlled trial to evaluate a medication monitoring system for TB treatment18
0.056378126144409